NIM
LEGN icon

NEOS Investment Management’s Legend Biotech LEGN Stock Holding History

NEOS Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92,017
Closed -$2M – 619
2025
Q4 		$2M Buy
92,017
+37,474
+69% +$1.07M 0.01% 478
2025
Q3 		$1.78M Sell
54,543
-2,145
-4% -$79.2K 0.01% 455
2025
Q2 		$2.01M Buy
56,688
+4,680
+9% +$152K 0.02% 369
2025
Q1 		$1.76M Buy
52,008
+40,646
+358% +$1.46M 0.03% 348
2024
Q4 		$370K Sell
11,362
-12,537
-52% -$519K 0.01% 540
2024
Q3 		$1.16M Buy
23,899
+1,507
+7% +$80.3K 0.04% 346
2024
Q2 		$992K Buy
22,392
+15,310
+216% +$706K 0.04% 330
2024
Q1 		$397K Buy
7,082
+1,697
+32% +$102K 0.02% 440
2023
Q4 		$324K Buy
+5,385
New +$341K 0.03% 368

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NEOS Investment Management's LEGN Position: Q1 2026 in Review

NEOS Investment Management sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 92,017 shares — an estimated $2M sold.

NEOS Investment Management first reported a position in LEGN in Q4 2023 and held it in 9 quarters. The position peaked at $2.01M in Q2 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • NEOS Investment Management reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 92,017 Legend Biotech shares in Q1 2026, an estimated $2M.
  • NEOS Investment Management first reported a position in Legend Biotech in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Legend Biotech position peaked at $2.01M in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.